Physician profile
David J Kessler
NPI 1447251178
$64,529.21
in general payments reported to CMS, 2019-2025
32 companies · $8,057 in 2025
The $8,057 reported for 2025 was more than what 76% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $21K · 2020: $3,929 · 2021: $3,446 · 2022: $6,580 · 2023: $12K · 2024: $8,606 · 2025: $8,057.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $8,313 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $4,275 · Travel and Lodging: $2,736.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13,773.13 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $8,312.50 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $4,275.00 |
| Travel and Lodging | $2,735.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $33,516.76 | 2019-2025 | Ensite Precision, Ensite, Gallant |
| Pfizer INC. | $12,458.80 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $6,545.60 | 2019-2024 | Xarelto |
| Biosense Webster, INC. | $3,262.79 | 2021-2025 | Carto 3, Qdot Micro Catheter, Nuvision Ice Catheter |
| Medtronic Vascular, INC. | $2,549.58 | 2019-2020 | |
| Medtronic, INC. | $2,295.43 | 2021-2024 | Azure Xt Dr Mri Surescan, Affera Mapping System, Selectsite |
| E.R. Squibb & Sons, L.L.C. | $823.53 | 2019-2025 | Camzyos, Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $684.36 | 2019-2025 | Lifevest |
| Sanofi-Aventis U.S. LLC | $481.29 | 2019-2024 | |
| Boston Scientific Corporation | $377.38 | 2023-2025 | Watchman Flx, General - Therapies, Polaris X |
| Impulse Dynamics (USA) INC. | $214.55 | 2023 | Optimizer |
| Becton, Dickinson and Company | $138.58 | 2025 | |
| Irhythm Technologies, INC. | $127.61 | 2021-2022 | |
| Cook Medical LLC | $126.58 | 2020 | |
| Novartis Pharmaceuticals Corporation | $123.46 | 2021-2023 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $121.75 | 2022-2024 | Praluent, Evkeeza |
| Atricure, INC. | $121.54 | 2023-2025 | Epi-Sense Guided Coagulation System With Visitrax, Atriclip Laa Exclusion System |
| Ebr Systems, INC. | $110.57 | 2025 | |
| Cardiva Medical, INC. | $73.19 | 2022-2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Baxter Healthcare | $48.78 | 2019-2025 | Hillrom - Cardiac Ambulatory Monitor |
| Inspire Medical Systems, INC. | $47.99 | 2025 | Inspire |
| Cardiofocus, INC. | $47.69 | 2023 | Heartlight System |
| Glaxosmithkline, LLC. | $43.86 | 2025 | Shingrix, Arexvy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $34.99 | 2019 | |
| Kiniksa Pharmaceuticals International, Plc | $33.29 | 2024 | Arcalyst |
| Davol INC. | $28.72 | 2022 | |
| Innovation Technologies INC | $18.57 | 2022 | |
| Lundbeck LLC | $18.22 | 2019 | |
| Ethicon US, LLC | $16.82 | 2019 | |
| G Medical Diagnostic Services, INC. | $14.58 | 2022 | |
| Convatec INC. | $12.39 | 2021 | |
| Cvrx, INC. | $9.96 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Kessler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.